From protecting the developing infant brain to supporting cognitive function in adults, a growing body of research supports lutein as an important nutrient for brain function throughout all stages of life. No other lutein brand is backed by more research on brain health than FloraGLO Lutein. Researchers and leading vitamin manufacturers all over the world rely on the quality and safety profile of FloraGLO and its proven efficacy.
Currently, FloraGLO is the only lutein brand used in 14 publications of interventional studies investigating the effects of lutein for infants. FloraGLO is also the only lutein brand that is Generally Recognized As Safe (GRAS) for use in term and pre-term infant formula. Therefore, FloraGLO is the number one choice to provide lutein for prenatal, infant and pediatric products for neural development and protection during infancy and childhood.
Brain functions like processing speed and working memory can decline with age. Research shows that FloraGLO Lutein can help individuals maintain brain health and function. FloraGLO is unique in the market with body of 8 publications of interventional studies investigating the effects of FloraGLO Lutein supplementation on cognition in healthy adults.
Kemin uses only the best growing and harvesting practices to cultivate its elite dietary ingredients. Our proprietary lutein manufacturing process has been developed and refined over the last 20 years.
Our marigold flowers are grown in India, meticulously handpicked, and extracted resulting in marigold oleoresin which is shipped to Kemin headquarters in Des Moines, Iowa where it is further processed into unesterified (free) FloraGLO Lutein. Each step of the manufacturing process is carefully controlled to ensure a quality naturally-sourced lutein.
If you're interested in formulating with FloraGLO Lutein, fill out the form below and a Kemin representative will be in touch shortly.
Recommended conditions of use: Daily intake of 10 mg of FloraGLO Lutein
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Companies need to make their own determination regarding whether there is a substantiation for the claims for their finished products, taking into consideration product formulation, dosage and directions for use, and for ascertaining the proper use of this product with regard to applicable laws and regulations.
Certain statements may not be applicable in all geographical regions. Product labeling and associated claims may differ based upon government requirements.
1. PubMed, 2016.
2. Based on the results of the US Quintiles IMS National Disease and Therapeutic Index (NDTI) syndicated report among US physicians who recommend a dietary supplement with lutein for eye health between April 1, 2016 to March 31, 2017.
3. Roberts, Richard. “Methods of Treating Ocular Disorders.” Kemin Industries, Inc., assignee. Patent US9226940 B2. 5 Jan. 2016.
4. U.S. Food & Drug Administration, 2004. GRAS Notice Inventory, GRN No. 140, 221 and 390.